A complete analysis of NMDA receptor subunits in periaqueductal grey and ventromedial medulla of morphine tolerant mice

Drug and Alcohol Dependence

Volumn 86, Issue 2-3, 2007, Pages 290-293

  Kozela, Ewa ^a   Popik, Piotr ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Morphine; NMDA receptor subunits; Periaqueductal grey; Rostral ventromedial medulla; Tolerance

Indexed keywords

MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2C; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2D;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; IMMUNOBLOTTING; MALE; MEDULLA OBLONGATA; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; DRUG TOLERANCE; IMMUNOBLOTTING; MEDULLA OBLONGATA; MICE; MICE, INBRED C57BL; MORPHINE; PERIAQUEDUCTAL GRAY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 33751394667     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2006.06.018     Document Type: Article

References (23)

1. Basbaum A.I., and Fields H.L. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu. Rev. Neurosci. 7 (1984) 309-338
2. Chen B.S., Braud S., Badger J.D., Isaac J.T., and Roche K.W. Regulation of NR1/NR2C NMDA receptors by phosphorylation. J. Biol. Chem. 281 (2006) 16583-16590
3. Commons K.G., van Bockstaele E.J., and Pfaff D.W. Frequent colocalization of mu opioid and NMDA-type glutamate receptors at postsynaptic sites in periaqueductal gray neurons. J. Comp. Neurol. 408 (1999) 549-559
4. Fitzgerald L.W., Ortiz J., Hamedani A.G., and Nestler E.J. Drugs of abuse and stress increase the expression of glur1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents. J. Neurosci. 16 (1996) 274-282
5. He L., and Whistler J.L. An opiate cocktail that reduces morphine tolerance and dependence. Curr. Biol. 15 (2005) 1028-1033
6. Inoue M., Mishina M., and Ueda H. Locus-specific rescue of GluRepsilon1 NMDA receptors in mutant mice identifies the brain regions important for morphine tolerance and dependence. J. Neurosci. 23 (2003) 6529-6536
7. Kozela E., Pilc A., and Popik P. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-d-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice. Psychopharmacology 165 (2003) 245-251
8. Lane D.A., Tortorici V., and Morgan M.M. Behavioral and electrophysiological evidence for tolerance to continuous morphine administration into the ventrolateral periaqueductal gray. Neuroscience 125 (2004) 63-69
9. Laurie D.J., Bartke I., Schoepfer R., Naujoks K., and Seeburg P.H. Regional, developmental and interspecies expression of the four NMDAR2 subunits, examined using monoclonal antibodies. Brain Res. Mol. Brain Res. 51 (1997) 23-32
10. Laurie D.J., and Seeburg P.H. Ligand affinities at recombinant N-methyl-d-aspartate receptors depend on subunit composition. Eur. J. Pharmacol. 268 (1994) 335-345
11. Lim G., Wang S., Zeng Q., Sung B., Yang L., and Mao J. Expression of spinal NMDA receptor and PKCgamma after chronic morphine is regulated by spinal glucocorticoid receptor. J. Neurosci. 25 (2005) 11145-11154
12. Mao J. NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity. Brain Res. Brain Res. Rev. 30 (1999) 289-304
13. Martin G., Guadano-Ferraz A., Morte B., Ahmed S., Koob G.F., De Lecea L., and Siggins G.R. Chronic morphine treatment alters N-methyl-d-aspartate receptors in freshly isolated neurons from nucleus accumbens. J. Pharmacol. Exp. Ther. 311 (2004) 265-273
14. Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H., Burnashev N., Sakmann B., and Seeburg P.H. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256 (1992) 1217-1221
15. Narita M., Aoki T., and Suzuki T. Molecular evidence for the involvement of NR2B subunit containing N-methyl-d-aspartate receptors in the development of morphine-induced place preference. Neuroscience 101 (2000) 601-606
16. Siggins G.R., Martin G., Roberto M., Nie Z., Madamba S., and De Lecea L. Glutamatergic transmission in opiate and alcohol dependence. In: Moghaddam B., and Wolf M.E. (Eds). Ann. N.Y. Acad. Sci. (2003) 196-211
17. Sucher N.J., Brose N., Deitcher D.L., Awobuluyi M., Gasic G.P., Bading H., Cepko C.L., Greenberg M.E., Jahn R., and Heinemann S.F. Expression of endogenous NMDAR1 transcripts without receptor protein suggests post-transcriptional control in PC12 cells. J. Biol. Chem. 268 (1993) 22299-22304
18. Tortorici V., Robbins C.S., and Morgan M.M. Tolerance to the antinociceptive effect of morphine microinjections into the ventral but not lateral-dorsal periaqueductal gray of the rat. Behav. Neurosci. 113 (1999) 833-839
19. Trujillo K.A., and Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251 (1991) 85-87
20. Turchan J., Maj M., and Przewlocka B. The effect of drugs of abuse on NMDAR1 receptor expression in the rat limbic system. Drug Alcohol Depend. 72 (2003) 193-196
21. Wenzel A., Scheurer L., Kunzi R., Fritschy J.M., Mohler H., and Benke D. Distribution of NMDA receptor subunit proteins NR2A, 2B, 2C and 2D in rat brain. NeuroReport 7 (1995) 45-48
22. Zhu H., Brodsky M., Gorman A.L., and Inturrisi C.E. Region-specific changes in NMDA receptor mRNA induced by chronic morphine treatment are prevented by the co-administration of the competitive NMDA receptor antagonist LY274614. Brain Res. Mol. Brain Res. 114 (2003) 154-162
23. Zhu H., Jang C.G., Ma T., Oh S., Rockhold R.W., and Ho I.K. Region specific expression of NMDA receptor NR1 subunit mRNA in hypothalamus and pons following chronic morphine treatment. Eur. J. Pharmacol. 365 (1999) 47-54